Roche presents new data at World Muscle Society (WMS) 2021 highlighting new advances for people living with rare neuromuscular disorders

Basel, 24 September 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced data from across its growing neuromuscular portfolio at the World Muscle Society (WMS) Virtual Congress 20 – 24 September 2021. The presentations included additional results from the RAINBOWFISH study, evaluating the efficacy and safety of Evrysdi® (risdiplam) in babies with pre-symptomatic spinal muscular atrophy (SMA) from birth to six weeks of age and data supporting the continued clinical investig ation of gene therapy, SRP-9001, in Duchenne muscular dystrophy (DMD).“These new data for Evrysdi may help extend the potential benefits of this medicine to the youngest SMA patients. Also, the data from SRP-9001 have helped to optimise the design of the upcoming Phase III trial for DMD,” said Levi Garraway, M.D., Ph.D, Roche’s Chief Medical Officer and Head of Global Product Development. “Our goal is to continue to lead the way in developing transformative medicines for neuromuscular diseases. We are grateful for the partnerships that are helping us to develop new therapies for people impacted by these devastating rare diseases.”At WMS 2021, data from the ongoing open label RAINBOWFISH study were presented. Four out of five of those treated with Evrysdi for at least 12 months achieved standing and walking independently within the World Health Organization windows for healthy children. In addition, all five babies maintained the ability to swallow and were able t...
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news

Related Links:

ConclusionsLUS allowed the visualization of a particular and rare disease such as anthracosis-associated rounded atelectasis, thus leading to a more correct and faster patient management.
Source: Journal of Ultrasound - Category: Radiology Source Type: research
We report the case of a 4-year-old boy who initially developed a widespread popular–pustular rash 2 weeks after his 12-month measles, mumps, and rubella vaccinations. These resolved with scarring then recurred following his 24-month vaccinations. Multiple skin biopsies were negative for infectious organisms and showed a granulomatous infiltrate with perforation and necrobiosis. The differential diagnosis included perforating granuloma annulare, infection, or rheumatoid nodules. At the age of 4, he developed fever, hepatosplenomegaly, pancytopenia and other laboratory abnormalities, requiring hospitalization. A number...
Source: The American Journal of Dermatopathology - Category: Pathology Tags: Extraordinary Case Report Source Type: research
DiscussionThe majority of doulas who participated in this study stated that their racial identity strongly influenced their work, particularly when working with women of the same race or ethnicity due to their shared identities. Several participants initially became doulas because of a desire to alleviate disparities in birth outcomes for women of color. This suggests a commitment on the part of the study participants to serving their communities and to bridging the gap between women of color and the health care system. Several participants also noted that they feel alienated by both the health care system and the mainstre...
Source: Journal of Midwifery and Women's Health - Category: Midwifery Authors: Tags: Original Research Source Type: research
The United States will restrict travel for non-U.S. citizens from South Africa and seven other countries starting on Monday as a new Covid variant emerges. #southafrica
Source: Reuters: Health - Category: Consumer Health News Source Type: news
Top U.S. infectious disease official Anthony Fauci said on Friday that a ban on flights from southern Africa was a possibility and the United States was rushing to gather data on the new COVID-19... #anthonyfauci
Source: Reuters: Health - Category: Consumer Health News Source Type: news
At home COVID-19 testing is still not widely available in the United States, as it is in many other nations, and some are pointing to the FDA's over-insistence on perfectly accurate tests as the reason why.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Source: Chemical and Engineering News - Category: Chemistry Authors: Source Type: research
Former Trump White House chief of staff Stephen Bannon is reportedly pushing for documents to be released in his court case on contempt-of-Congress charges, with lawyers indicating he wants to use... #trump #chiefofstaff #stephenbannon
Source: Reuters: Health - Category: Consumer Health News Source Type: news
Basel, 24 September 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced data from across its growing neuromuscular portfolio at the World Muscle Society (WMS) Virtual Congress 20 – 24 September 2021. The presentations included additional results from the RAINBOWFISH study, evaluating the efficacy and safety of Evrysdi® (risdiplam) in babies with pre-symptomatic spinal muscular atrophy (SMA) from birth to six weeks of age and data supporting the continued clinical investig ation of gene therapy, SRP-9001, in Duchenne muscular dystrophy (DMD).“These new data for Evrysdi may help extend the potential ben...
Source: Roche Media News - Category: Pharmaceuticals Source Type: news
Basel, 28 April 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today presented 1-year data from FIREFISH Part 2, a pivotal global study evaluating risdiplam in infants aged 1 – 7 months old with symptomatic Type 1 spinal muscular atrophy (SMA). The study met its primary endpoint with 29% of infants (12/41; p
Source: Roche Media News - Category: Pharmaceuticals Source Type: news
More News: Babies | Boys | Brain | Child Development | Children | Clinical Trials | European Medicines Agency (EMA) | Food and Drug Administration (FDA) | Gene Therapy | Genetics | International Medicine & Public Health | Motor Neurone Disease | Muscular Dystrophy | Neurology | Neuroscience | Partnerships | Perinatology & Neonatology | Pharmaceuticals | Politics | Rare Diseases | Reflex Sympathetic Dystrophy | Respiratory Medicine | Science | Spinal Muscular Atrophy | Statistics | Study | USA Health | WHO